Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/19/2004 | US20040033983 Dietetic mixtures comprising polyglucomannans, excipients and lipase inhibitors such as orlistat |
02/19/2004 | US20040033982 Viral inhibition by n-docosanol |
02/19/2004 | US20040033968 Comprises fungicides and moisturizers; side effect reduction |
02/19/2004 | US20040033960 Ophthalmic irrigating solution adapted for use in lasik surgery |
02/19/2004 | US20040033959 Improved bioavailability |
02/19/2004 | US20040033955 Treatment of ophthalmic infections using antimicrobial peptides |
02/19/2004 | US20040033949 Use of VEGF for treating bone defects |
02/19/2004 | US20040033938 Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
02/19/2004 | US20040033933 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
02/19/2004 | US20040033275 Extracted with ethanol/water mixed with a heavy metal chelator; primary extract is concentrated with Indian Sterculia gum or one or more polymers such as a polysaccharides |
02/19/2004 | US20040033267 Nanoparticulate compositions of angiogenesis inhibitors |
02/19/2004 | US20040033266 Pharmaceutically active particles of a monomodal particle size distribution and method |
02/19/2004 | US20040033265 Composite matrix containing chitosan derivatives and a process for making the same |
02/19/2004 | US20040033264 Composite hydrogel drug delivery systems |
02/19/2004 | US20040033263 Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation |
02/19/2004 | US20040033262 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
02/19/2004 | US20040033261 Gellan gum tablet film coating |
02/19/2004 | US20040033259 Particularly levothyroxine sodium; unit dosage form containing an alditol, a saccharide, and optionally further excipients |
02/19/2004 | US20040033258 Compression molded blend of a basic medicinal component having an unpleasant taste, a saccharide, a polyanionic polymer, a corrigent, and carboxymethylcellulose; quickly disintegrating in the oral cavity. |
02/19/2004 | US20040033257 Pharmaceutical formulation in a drug delivery system and process for preparing the same |
02/19/2004 | US20040033256 Long-acting insulin formulation that may be aerosolized for pulmonary administration. |
02/19/2004 | US20040033255 For preventing, inhibiting, and/or diminishing the intentional and/ or inadvertent misuse or abuse of a transdermal delivery device |
02/19/2004 | US20040033254 Transdermal drug delivery system with improved water absorbability and adhesion properties |
02/19/2004 | US20040033253 Transdermal-delivery device |
02/19/2004 | US20040033250 Implantable polymeric device for sustained release of buprenorphine |
02/19/2004 | US20040033245 Pharmaceutical suspensions, compositions and methods |
02/19/2004 | US20040033242 Two dimensional polymer that generates nitric oxide |
02/19/2004 | US20040033241 The botulinum toxin is released from the carrier upon implantation in a human patient. |
02/19/2004 | US20040033233 Dried powder form in sachet or in capsule of root, bark and wood of Philippine Narra tree (Pterocarpus Indicus) |
02/19/2004 | US20040033228 High protein concentration, a pH of between about 4 and about 8, and enhanced stability; tumor necrosis factor alpha (tnf-alpha) |
02/19/2004 | US20040033220 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
02/19/2004 | US20040033202 Nanoparticulate sterol formulations and novel sterol combinations |
02/19/2004 | US20040033201 Aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids |
02/19/2004 | US20040032187 Devices for intrabody delivery of molecules and systems and methods utilizing same |
02/19/2004 | US20040032037 Equipped with line for transporting polar liquid phase, line for transporting organic liquid phase containing lipids, collecting receptacle for accommodating product lipid vesicles, means for conveying produced vesicles through lines |
02/19/2004 | US20040031447 Animal papilla disinfectants and method of improving microbial environment |
02/19/2004 | DE19930030B4 CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform CO-3 unsaturated fatty acids containing oral dosage form |
02/19/2004 | DE19860373B4 Mundpflegemittel und Verwendung von sphärischen Mikropartikeln The oral care composition and use of spherical microparticles |
02/19/2004 | DE10248412A1 Rapidly acting, easily administered suppositories for treatment and/or prophylaxis of hypoglycemia, preferably comprising monosaccharide (source) as active agent |
02/19/2004 | DE10236319A1 Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer |
02/19/2004 | DE10235475A1 Composition in the form of pellets containing benzimidazole useful for treating gastric disorders comprises an inert core to which a layer containing benzimidazole with microcrystalline cellulose is applied and outer layer |
02/19/2004 | DE10234784A1 Intravenös applizierbare, pharmazeutische Darreichungsform Administered Intravenously, pharmaceutical dosage form |
02/19/2004 | DE10234673A1 Heißschmelz-TTS zur Verabreichung von Rotigotin Hot melt TTS for the administration of rotigotine |
02/19/2004 | DE10217555A1 Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix Physiologically acceptable, phospholipid-containing, stable and hard matrix |
02/19/2004 | DE10214031A1 Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation Process for the preparation and application of micro- and nanoparticles by constructive micronization |
02/19/2004 | CA2809147A1 Compositions and process for delivering an additive |
02/19/2004 | CA2497452A1 Compositions and process for delivering an additive |
02/19/2004 | CA2495172A1 Active agent delivery systems, medical devices, and methods |
02/19/2004 | CA2495103A1 Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases |
02/19/2004 | CA2495071A1 Isosorbide mononitrate compositions and methods of their use |
02/19/2004 | CA2494911A1 Immunomodulatory compositions, methods of making, and methods of use thereof |
02/19/2004 | CA2494865A1 Electrospun amorphous pharmaceutical compositions |
02/19/2004 | CA2494716A1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
02/19/2004 | CA2494699A1 Palatable controlled-release formulation for companion animals |
02/19/2004 | CA2494186A1 Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method |
02/19/2004 | CA2494065A1 Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine |
02/19/2004 | CA2493120A1 Implantable artifical pancreas |
02/19/2004 | CA2491136A1 A chemical carrier |
02/18/2004 | EP1389469A1 Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid |
02/18/2004 | EP1389468A1 Compositions for promoting healing of bone fracture |
02/18/2004 | EP1389467A1 Therapeutic compositions for repairing chondropathy |
02/18/2004 | EP1389466A1 Immunopotentiators |
02/18/2004 | EP1389462A1 Amorphous cefditoren pivoxil composition and process for producing the same |
02/18/2004 | EP1389212A1 3,7-diazabicyclo 3.3.1] formulations as anti-arrythmic compounds |
02/18/2004 | EP1389211A1 3,7-diazybicyclo 3.3.1] formulations as antiarrhytmic compounds |
02/18/2004 | EP1389137A2 Compositions for protein delivery via the pulmonary route |
02/18/2004 | EP1389124A1 Palliative effects of morinda citrifolia oil and juice |
02/18/2004 | EP1389118A1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
02/18/2004 | EP1389115A2 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation |
02/18/2004 | EP1389109A1 Gastric acid secretion inhibiting composition |
02/18/2004 | EP1389108A2 Methods for selective immunomodulation using pimecrolimus |
02/18/2004 | EP1389106A1 Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
02/18/2004 | EP1389099A1 Delivery of beta-blockers through an inhalation route |
02/18/2004 | EP1389098A1 Delivery of antipsychotics through an inhalation route |
02/18/2004 | EP1389097A1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
02/18/2004 | EP1389096A1 Delivery of opioids through an inhalation route |
02/18/2004 | EP1389095A1 Delivery of antidepressants through an inhalation route |
02/18/2004 | EP1389094A1 Delivery of sedative-hypnotics trough an inhalation route |
02/18/2004 | EP1389093A2 Pharmaceutical formulation |
02/18/2004 | EP1389092A1 Abuse-resistant opioid dosage form |
02/18/2004 | EP1389091A1 Granular preparations of gaboxadol |
02/18/2004 | EP1389089A2 Method and composition for solubilising a biologically active compound with low water solubility |
02/18/2004 | EP1389086A1 Topical compositions containing nonimmunosuppressive cyclosporin-derivatives for treating hair loss |
02/18/2004 | EP1267932B1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
02/18/2004 | EP1240261B1 Medicament delivery device with moisture resistant coating |
02/18/2004 | EP1237408B1 Pour-on formulations |
02/18/2004 | EP1194136B1 Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract |
02/18/2004 | EP1187635B1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
02/18/2004 | EP1137407B1 Ophthalmic formulation comprising a beta blocker and carbopol |
02/18/2004 | EP1131089B1 Stable aqueous insulin preparations without phenol and cresol |
02/18/2004 | EP1082293B1 Formoterol polymorphs |
02/18/2004 | EP1032396B1 Sterilization of glucocorticosteroids |
02/18/2004 | EP0994696B1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
02/18/2004 | EP0967995B1 Composition comprising immunoglobulin |
02/18/2004 | EP0863765B1 Pharmaceutical compositions of cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
02/18/2004 | CN1476335A Freeze-dried pantoprazole preparation and pantoprazole injection |
02/18/2004 | CN1476330A Polymeric micelle containing cisplatin enclosed therein and use thereof |
02/18/2004 | CN1476327A Water-soluble liquid internal medicine |
02/18/2004 | CN1476325A Active agent delivery systems and methods for protecting and administering active agents |